Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Operating Expenses (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Operating Expenses for 2 consecutive years, with $25.0 million as the latest value for Q4 2023.

  • On a quarterly basis, Operating Expenses fell 6.59% to $25.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $77.6 million, a 26.55% decrease, with the full-year FY2024 number at $58.6 million, down 19.08% from a year prior.
  • Operating Expenses was $25.0 million for Q4 2023 at LENZ Therapeutics, roughly flat from $25.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $26.8 million in Q2 2022 to a low of $12.6 million in Q1 2023.